Diabetes Care
Skip to main page content
Home
Current Issue
Archive
Contact Us
Subscribe
Help
Alerts
RSS
Search
GO
Advanced Search »
User Name
Password
Sign In
Advertisement
Effects of the Dipeptidyl Peptidase-IV Inhibitor Vildagliptin on Incretin Hormones, Islet Function, and Postprandial Glycemia in Subjects With Impaired Glucose Tolerance
Online-Only Appendix
Files in this Data Supplement:
Figure A1: Disposition of Subjects
Figure A2: Plasma levels of active GIP at study endpoint during standard meal tests performed in subjects with IGT receiving vildagliptin or placebo.
Supplemental Figure Legends
This Article
Published online before print
October 18, 2007
, doi:
10.2337/dc07-1616
Diabetes Care
January 2008
vol. 31
no. 1
30-35
Abstract
Free
Full Text
Full Text (PDF)
»
Online-Only Appendix
Current Issue
February 2012, 35 (2)
From the Cover
Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival
Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program
High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects
Type 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation
Alert me to new issues of Diabetes Care
About Diabetes Care
Editorial Board
Instructions for Authors
Subscriptions
Advertising & Reprints
ADA's DiabetesPro
ADA Member Directory
More ADA Publications
Diabetes
Clinical Diabetes
Diabetes Spectrum
ADA Clinical Practice Recommendations
Scientific Sessions Abstracts
Books & Other Publications
Advertisement